Livzon Pharma announces share repurchase program update

Livzon Pharmaceutical Group (SZSE:000513) announced that on April 17, 2025, it repurchased 144,700 A-shares at the Shenzhen Stock Exchange, with prices ranging from RMB 34.46 to RMB 34.64 per share, for a total consideration of RMB 4,997,336. Additionally, the company noted that several H-share repurchases occurred throughout 2024 and early 2025 but are still pending cancellation. These H-share buybacks were executed on the Hong Kong Stock Exchange at various prices, with the latest transactions occurring on January 3, 2025. The company confirms that all buybacks comply with relevant regulations and previous disclosures.